{"sourcedb":"DevicePMAs@therightstef","sourceid":"P990009_S013","text":"Approval for an alternate kit configuration that contains a human thrombin component.  The device, as modified, will be marketed under the trade name floseal hemostatic matrix and is indicated for use in surgical procedures (other than in ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.","project":"consensus_PMA_Age_Indications"}